JP2013512954A - 置換インダゾール及びアザインダゾール化合物の生成に有効な中間体の合成方法 - Google Patents

置換インダゾール及びアザインダゾール化合物の生成に有効な中間体の合成方法 Download PDF

Info

Publication number
JP2013512954A
JP2013512954A JP2012543154A JP2012543154A JP2013512954A JP 2013512954 A JP2013512954 A JP 2013512954A JP 2012543154 A JP2012543154 A JP 2012543154A JP 2012543154 A JP2012543154 A JP 2012543154A JP 2013512954 A JP2013512954 A JP 2013512954A
Authority
JP
Japan
Prior art keywords
formula
metal catalyst
hydrogen
compound
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012543154A
Other languages
English (en)
Japanese (ja)
Inventor
ホセイン ラザヴィー
ジョナサン ティモシー リーヴズ
ソニア ロドリゲス
Original Assignee
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング filed Critical ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング
Publication of JP2013512954A publication Critical patent/JP2013512954A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2012543154A 2009-12-08 2010-12-01 置換インダゾール及びアザインダゾール化合物の生成に有効な中間体の合成方法 Pending JP2013512954A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26753809P 2009-12-08 2009-12-08
US61/267,538 2009-12-08
PCT/US2010/058594 WO2011071730A1 (en) 2009-12-08 2010-12-01 Process for synthesis of intermediates useful for making substituted indazole and azaindazole compounds

Publications (1)

Publication Number Publication Date
JP2013512954A true JP2013512954A (ja) 2013-04-18

Family

ID=43416915

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012543154A Pending JP2013512954A (ja) 2009-12-08 2010-12-01 置換インダゾール及びアザインダゾール化合物の生成に有効な中間体の合成方法

Country Status (17)

Country Link
US (1) US20110137042A1 (enExample)
EP (1) EP2509952A1 (enExample)
JP (1) JP2013512954A (enExample)
KR (1) KR20120101667A (enExample)
CN (1) CN102596908A (enExample)
AR (1) AR079324A1 (enExample)
AU (1) AU2010328480A1 (enExample)
BR (1) BR112012013582A2 (enExample)
CA (1) CA2782384A1 (enExample)
CL (1) CL2012001300A1 (enExample)
EA (1) EA201200820A1 (enExample)
IL (1) IL219274A0 (enExample)
IN (1) IN2012DN05081A (enExample)
MX (1) MX2012006524A (enExample)
PH (1) PH12012501153A1 (enExample)
TW (1) TW201144282A (enExample)
WO (1) WO2011071730A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2722923C (en) 2008-04-29 2016-08-02 Boehringer Ingelheim International Gmbh Indazole compounds as ccr1 receptor antagonists
EP2297112B1 (en) * 2008-05-06 2013-04-03 Boehringer Ingelheim International GmbH Pyrazole compounds as ccr1 antagonists
AP2739A (en) 2008-09-26 2013-09-30 Boehringer Ingelheim Int Azaindazole compounds as CCRI receptor antagonists
PL2491028T3 (pl) 2009-10-21 2014-05-30 Boehringer Ingelheim Int Związki indazolowe i pirazolopirydynowe jako antagoniści receptora CCR1
EP2493875B1 (en) 2009-10-27 2014-08-06 Boehringer Ingelheim International GmbH Heterocyclic compounds as ccr1 receptor antagonists
US8871786B2 (en) 2010-04-30 2014-10-28 Boehringer Ingelheim International Gmbh Azaindazole amide compounds as CCR1 receptor antagonists
US8546442B2 (en) 2010-12-23 2013-10-01 Boehringer Ingelheim International Gmbh Pyrazolopiperidine compounds as CCR1 receptor antagonists

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007505902A (ja) * 2003-09-18 2007-03-15 アストラゼネカ・アクチエボラーグ 好中球エラスターゼ阻害剤としての２−ピリドン誘導体およびその使用
JP2007505901A (ja) * 2003-09-18 2007-03-15 アストラゼネカ・アクチエボラーグ 好中球エラスターゼ阻害剤としての２−ピリドン誘導体およびそれらの使用
WO2010036632A1 (en) * 2008-09-26 2010-04-01 Boehringer Ingelheim International Gmbh Azaindazole compounds as ccr1 receptor antagonists

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242931A (en) * 1988-06-09 1993-09-07 Kyowa Hakko Kogyo Co., Ltd. Tricyclic compounds as TXA2 antagonists
US4999363A (en) * 1988-06-09 1991-03-12 Kyowa Hakko Kogyo Co., Ltd. Tricyclic compounds
US5750542A (en) * 1993-09-28 1998-05-12 Pfizer Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors
US5612360A (en) * 1992-06-03 1997-03-18 Eli Lilly And Company Angiotensin II antagonists
WO1994001415A1 (fr) * 1992-07-03 1994-01-20 Kumiai Chemical Industry Co., Ltd. Derive heterocyclique condense et desherbant
GB9304919D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
EP0657450B1 (en) * 1993-06-25 1998-09-09 KumaiI Chemical Industry Co., Ltd. Indazolesulfonylurea derivative, use thereof, and intermediate for production thereof
CA2207201A1 (en) * 1994-12-06 1996-06-13 Caroline Henry Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists
GB9519563D0 (en) * 1995-09-26 1995-11-29 Merck Sharp & Dohme Therapeutic agents
GB9523583D0 (en) * 1995-11-17 1996-01-17 Merck Sharp & Dohme Therapeutic agents
US5760028A (en) * 1995-12-22 1998-06-02 The Dupont Merck Pharmaceutical Company Integrin receptor antagonists
GB9615449D0 (en) * 1996-07-23 1996-09-04 Merck Sharp & Dohme Therapeutic agents
NZ503995A (en) * 1997-11-04 2003-02-28 Pfizer Prod Inc Indazole compounds, and pharmaceutical compositions and uses thereof, based on indazole bioisostere replacement of catechol in PDE4 inhibitors
US6331640B1 (en) * 1998-10-13 2001-12-18 Hoffmann-La Roche Inc. Diaminopropionic acid derivatives
CA2375920A1 (en) * 1999-06-14 2000-12-21 Eli Lilly And Company Compounds
AU5895500A (en) * 1999-06-29 2001-01-31 Cor Therapeutics, Inc. Novel indazole peptidomimetics as thrombin receptor antagonists
GB0030303D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030304D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030305D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030306D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds
US7211594B2 (en) * 2000-07-31 2007-05-01 Signal Pharmaceuticals, Llc Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
US20050009876A1 (en) * 2000-07-31 2005-01-13 Bhagwat Shripad S. Indazole compounds, compositions thereof and methods of treatment therewith
US7058826B2 (en) * 2000-09-27 2006-06-06 Amphus, Inc. System, architecture, and method for logical server and other network devices in a dynamically configurable multi-server network environment
US20020052373A1 (en) * 2000-10-26 2002-05-02 Zorn Stevin H. Combination treatment for dementia or cognitive deficits associated with alzheimer's disease and parkinson's disease
US6995162B2 (en) * 2001-01-12 2006-02-07 Amgen Inc. Substituted alkylamine derivatives and methods of use
ATE455104T1 (de) * 2001-11-01 2010-01-15 Icagen Inc Pyrazolamide zur anwendung in der behandlung von schmerz
TW200406385A (en) * 2002-05-31 2004-05-01 Eisai Co Ltd Pyrazole compound and pharmaceutical composition containing the same
TW200500341A (en) * 2002-11-12 2005-01-01 Astrazeneca Ab Novel compounds
SE0203825D0 (sv) * 2002-12-20 2002-12-20 Astrazeneca Ab Novel fused heterocycles and uses thereof
MXPA05009595A (es) * 2003-03-12 2005-11-04 Celgene Corp Compuestos 7-amino-isoindolilo y sus usos farmaceuticos.
US7129264B2 (en) * 2003-04-16 2006-10-31 Bristol-Myers Squibb Company Biarylmethyl indolines and indoles as antithromboembolic agents
US20040220170A1 (en) * 2003-05-01 2004-11-04 Atkinson Robert N. Pyrazole-amides and sulfonamides as sodium channel modulators
EP1664052B1 (en) * 2003-08-15 2009-02-18 AstraZeneca AB Fused heterocycles as inhibitors of glutamate racemase (muri)
GB0504828D0 (en) * 2005-03-09 2005-04-13 Merck Sharp & Dohme Therapeutic agents
PT1860941E (pt) * 2005-03-16 2008-12-22 Basf Se Bifenil-n-(4-piridil)metilsulfonamidas
AU2006247136C1 (en) * 2005-05-17 2020-01-16 Bausch + Lomb Ireland Limited Compositions and methods for treatment of eye disorders
JP5155864B2 (ja) * 2005-09-01 2013-03-06 イーライ リリー アンド カンパニー ５−ＨＴ２Ｃ受容体アゴニストとしての６−アリールアルキルアミノ−２，３，４，５−テトラヒドロ−１Ｈ−ベンゾ［ｄ］アゼピン
JP2009513677A (ja) * 2005-10-25 2009-04-02 スミスクライン・ビーチャム・コーポレイション 化合物
WO2007113226A1 (en) * 2006-03-31 2007-10-11 Novartis Ag Organic compounds
PE20081775A1 (es) * 2006-12-20 2008-12-18 Bristol Myers Squibb Co Compuestos macrociclicos como inhibidores del factor viia
GB0716292D0 (en) * 2007-08-21 2007-09-26 Biofocus Dpi Ltd Imidazopyrazine compounds
CA2699631A1 (en) * 2007-10-31 2009-05-07 Nissan Chemical Industries, Ltd. Pyridazinone compounds and p2x7 receptor inhibitors
CA2722923C (en) * 2008-04-29 2016-08-02 Boehringer Ingelheim International Gmbh Indazole compounds as ccr1 receptor antagonists
EP2297112B1 (en) * 2008-05-06 2013-04-03 Boehringer Ingelheim International GmbH Pyrazole compounds as ccr1 antagonists

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007505902A (ja) * 2003-09-18 2007-03-15 アストラゼネカ・アクチエボラーグ 好中球エラスターゼ阻害剤としての２−ピリドン誘導体およびその使用
JP2007505901A (ja) * 2003-09-18 2007-03-15 アストラゼネカ・アクチエボラーグ 好中球エラスターゼ阻害剤としての２−ピリドン誘導体およびそれらの使用
WO2010036632A1 (en) * 2008-09-26 2010-04-01 Boehringer Ingelheim International Gmbh Azaindazole compounds as ccr1 receptor antagonists

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6013062888; 第５版実験化学講座１４　有機化合物の合成ＩＩ , 2005, ３５２-３５６ *

Also Published As

Publication number Publication date
CN102596908A (zh) 2012-07-18
KR20120101667A (ko) 2012-09-14
IL219274A0 (en) 2012-06-28
BR112012013582A2 (pt) 2016-07-05
TW201144282A (en) 2011-12-16
CL2012001300A1 (es) 2012-09-07
EP2509952A1 (en) 2012-10-17
IN2012DN05081A (enExample) 2015-10-09
AU2010328480A1 (en) 2012-05-17
PH12012501153A1 (en) 2012-10-22
US20110137042A1 (en) 2011-06-09
CA2782384A1 (en) 2011-06-16
EA201200820A1 (ru) 2013-01-30
WO2011071730A1 (en) 2011-06-16
MX2012006524A (es) 2012-07-17
AR079324A1 (es) 2012-01-18

Similar Documents

Publication Publication Date Title
JP2013512954A (ja) 置換インダゾール及びアザインダゾール化合物の生成に有効な中間体の合成方法
EP2300431B1 (en) Process for the manufacture of an intermediate in the synthesis of dabigatran
JP5667576B2 (ja) トランス４−アミノ−シクロヘキシル酢酸エチル・エステルＨＣｌの製法
JP2014501719A (ja) キラルスピロ−ピリジルアミドフォスフィン配位子化合物、その合成方法及びその利用
TW499409B (en) Method for preparing of L-phenylephrine hydrochloride
CN102285891A (zh) 一种由芳香硝基化合物催化加氢制备芳胺的方法
WO2016055015A1 (zh) 一种不对称还原法制备西他列汀中间体的方法
CN105934430B (zh) 制备1‑烷基‑3‑二氟甲基‑5‑氟‑1h‑吡唑‑4‑甲醛和1‑烷基‑3‑二氟甲基‑5‑氟‑1h‑吡唑‑4‑甲酸酯的方法
CN110028436B (zh) 一种沃诺拉赞关键中间体的制备方法
CN114181077B (zh) 一种合成氨甲环酸的方法
KR101413877B1 (ko) 펙소페나딘의 제조 방법
JP3890452B2 (ja) アミノメチルピリジン化合物の製造法
JP6182507B2 (ja) ２，３−ジハロゲノアニリンの製造方法
CN102766147B (zh) 一种芬司匹利及其氢卤酸盐的制备方法
JP4769464B2 (ja) アルコール化合物の製造方法
JP4896476B2 (ja) メチルオキシメチルアミノピリジン誘導体及びその製造方法
JP5797108B2 (ja) ２−インダノールの製造方法
JP2005170848A (ja) ２，３−ジアミノピリジン類の製造方法
CN102584609B (zh) 一种沙美特罗的制备方法
CN114875434A (zh) 一种亚胺类化合物胺化的电化学方法
JP2004067592A (ja) アミノ−フェニルピペリジンの製造法
CN101993413A (zh) 一种制备4-吡啶丙醇的方法
JP2003192667A (ja) 光学活性３−ヒドロキシピロリジン誘導体の製造方法
JP2008297259A (ja) シス−アミノシクロヘキサンカルボン酸の製造方法
JP2002326978A (ja) ４−アミノシクロヘキシル酢酸またはそのエステルの製造法

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131224

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140908